List Headline Image
Updated by KemwellBiopharma KemwellBiopharma on Oct 11, 2019
 REPORT
1 items   1 followers   0 votes   0 views

Monoclonal Antibody Development

Monoclonal antibodies (mAbs) are antigen-recognizing glycoproteins that are made by identical immune cells, all of which are clones of a unique parent cell. Kemwell has signed a contract to manufacture and supply drug substance with its state-of-art mammalian cell culture for Phase 3 clinical trials, conducted by the US.

Kemwell Biopharma Selected to Manufacture the Monoclonal Antibody Drug Substance For a US Phase 3 Clinical Trial

Kemwell has signed a contract to manufacture and supply drug substance with it’s state-of-art mammalian cell culture for Phase 3 clinical trials, conducted by the US. Read more.